RA CAPITAL MANAGEMENT, LLC Insider Trading $ETNB 89bio, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for RA CAPITAL MANAGEMENT, LLC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of RA CAPITAL MANAGEMENT, LLC. RA CAPITAL MANAGEMENT, LLC is 10% Owner in LIPID SCIENCES INC/ ($LIPD) and 10% Owner in TG THERAPEUTICS, INC. ($TGTX) and Director in KalVista Pharmaceuticals, Inc. ($CBYL) and 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and Director in Dicerna Pharmaceuticals Inc ($DRNA) and Director in Kala Pharmaceuticals, Inc. ($KALA) and Director in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in Verastem, Inc. ($VSTM) and 10% Owner in Forma Therapeutics Holdings, Inc., ($FMTX) and 10% Owner in Aclaris Therapeutics, Inc. ($ACRS) and in G1 Therapeutics, Inc. ($GTHX) and 10% Owner in Synthorx, Inc. ($THOR) and 10% Owner in scPharmaceuticals Inc. ($SCPH) and Director in Wave Life Sciences Ltd. ($WVE) and 10% Owner in Vaxcyte, Inc. ($PCVX) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and in ARVINAS INC. ($ARVN) and 10% Owner in Iterum Therapeutics plc ($ITRM) and 10% Owner in IMARA Inc. ($IMRA) and Director in Satsuma Pharmaceuticals, Inc. ($STSA) and 10% Owner in Inozyme Pharma, Inc. ($INZY) and 10% Owner in PMV Pharmaceuticals, Inc. ($PMVP) and Director in Solid Biosciences Inc. ($SLDB) and Director in Eidos Therapeutics, Inc. ($EIDX) and 10% Owner in Inhibrx, Inc. ($INBX) and 10% Owner in Orchard Therapeutics plc ($ORTX) and Director in Orchard Therapeutics plc ($ORTX) and Director in Werewolf Therapeutics, Inc. ($HOWL) and 10% Owner in Nkarta, Inc. ($NKTX) and Director in Nkarta, Inc. ($NKTX) and 10% Owner in Phathom Pharmaceuticals, Inc. ($PHAT) and Director in 89bio, Inc. ($ETNB) and 10% Owner in Pandion Therapeutics, Inc. ($PAND) and 10% Owner in iTeos Therapeutics, Inc. ($ITOS) and Director in iTeos Therapeutics, Inc. ($ITOS) and Director in Vor Biopharma Inc. ($VOR) and 10% Owner in Dyne Therapeutics, Inc. ($DYN).

RA CAPITAL MANAGEMENT, LLC in 89bio, Inc.

Trading Symbol: ETNB
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: Director
Holdings: 4,736,214 shares
Latest Transaction: Sep 21 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of RA CAPITAL MANAGEMENT, LLC in 89bio, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ETNB, ACRS, ARVN, DRNA, DYN, EIDX, FMTX, GTHX, IMRA, INBX, INZY, ITOS, ITRM, KALA, KALV, LIPD, NKTX, ORTX, PAND, PHAT, PMVP, RARX, RYTM, STSA, SCPH, SLDB, THOR, TGTX, PCVX, VSTM, VOR, WVE, HOWL

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Sep 21 2020ETNB89bio, Inc.RA CAPITAL MANAGEMENT, L.P.DirectorBuyP28.001,300,00036,400,0004,736,2143.4 M to 4.7 M (+37.83 %)
Jul 10 2020ETNB89bio, Inc.RA CAPITAL MANAGEMENT, L.P.DirectorBuyP27.50275,0007,562,5003,436,2143.2 M to 3.4 M (+8.70 %)
Nov 13 2019ETNB89bio, Inc.RA CAPITAL MANAGEMENT, L.P.DirectorOption ExerciseC0.0010,327,77700
Nov 13 2019ETNB89bio, Inc.RA CAPITAL MANAGEMENT, L.P.DirectorOption ExerciseC0.0010,327,77700
Nov 13 2019ETNB89bio, Inc.RA CAPITAL MANAGEMENT, L.P.DirectorBuyC0.001,661,21403,161,2141.5 M to 3.2 M (+110.75 %)
Nov 13 2019ETNB89bio, Inc.RA CAPITAL MANAGEMENT, L.P.DirectorBuyC0.001,661,21403,161,2141.5 M to 3.2 M (+110.75 %)
Nov 13 2019ETNB89bio, Inc.RA CAPITAL MANAGEMENT, L.P.DirectorBuyP16.001,500,00024,000,0001,500,0000 to 1.5 M
Nov 13 2019ETNB89bio, Inc.RA CAPITAL MANAGEMENT, L.P.DirectorBuyP16.001,500,00024,000,0001,500,0000 to 1.5 M

Page:   1